Skip to main content
Earnings Labs
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) Earnings Dates & History

AMEX·Healthcare·Biotechnology

$1.68

-1.74%

Mkt Cap $2.20M

EPS — Estimate vs Actual

Quarterly History

Q3 2025

Aug 28, 2025

—$101.00K——-$0.21—
Q2 2025

Apr 14, 2025

—$101.00K—-$0.24-$0.21+10.68%
Q4 2024

Dec 26, 2024

$150.00K$179.00K+19.33%-$0.27-$0.43-59.26%
Q3 2024

Sep 26, 2024

$100.00K$158.00K+58.00%-$0.36-$0.40-11.11%
Q2 2024

Jun 27, 2024

$150.00K$158.00K+5.33%-$0.40-$0.65-62.50%
Q1 2024

Mar 28, 2024

$200.00K$155.00K-22.50%-$5.40-$6.20-14.81%
Q4 2023

Nov 30, 2023

$200.00K$196.00K-2.00%-$8.60-$8.60+0.00%
Q3 2023

Aug 31, 2023

$200.00K$196.00K-2.00%-$10.80-$8.00+25.93%
Q2 2023

Jun 1, 2023

—$196.00K—-$1.52-$13.00-755.26%
Q1 2023

Mar 30, 2023

—$197.00K—-$11.40-$22.20-94.74%
Q4 2022

Nov 25, 2022

$300.00K$204.00K-32.00%-$20.00-$18.00+10.00%
Q3 2022

Aug 25, 2022

$250.00K$204.00K-18.40%-$18.00-$16.00+11.11%
Q2 2022

May 26, 2022

$133.33K$205.00K+53.75%-$24.00-$18.00+25.00%
Q1 2022

Mar 24, 2022

$266.67K$204.00K-23.50%-$36.00-$38.00-5.56%
Q4 2021

Nov 26, 2021

$120.00K$251.00K+109.17%-$20.00-$38.00-90.00%
Q3 2021

Aug 26, 2021

$120.00K$250.00K+108.33%-$24.00-$38.00-58.33%
Q2 2021

May 27, 2021

—$148.00K—-$34.00-$24.00+29.41%
Q1 2021

Mar 25, 2021

—$150.00K—-$26.00-$60.00-130.77%
Q4 2020

Nov 30, 2020

—$211.00K—-$50.00-$48.00+4.00%
Q3 2020

Aug 27, 2020

$275.40K$204.00K-25.93%-$56.00-$60.00-7.14%
Q2 2020

Jun 1, 2020

$54.40K$198.00K+263.97%-$118.00-$144.00-22.03%
Q1 2020

Mar 27, 2020

—$192.00K—-$178.00-$120.00+32.58%
Q4 2019

Nov 29, 2019

—$1.15M—-$116.00-$180.00-55.17%
Q3 2019

Aug 30, 2019

$295.25K$389.00K+31.75%-$160.00-$240.00-50.00%
Q2 2019

May 29, 2019

—$299.00K—-$388.00-$240.00+38.14%
Q1 2019

Mar 28, 2019

—$289.00K——-$539.73—
Q4 2018

Nov 30, 2018

—$2.63M—-$119.94-$1.29+98.92%
Q3 2018

Aug 31, 2018

—$270.00K——-$179.91—
Q2 2018

Jun 1, 2018

—$632.00K—-$239.88-$299.85-25.00%
Q1 2018

Mar 23, 2018

—$105.02K—-$449.78-$179.91+60.00%
Q4 2017

Nov 27, 2017

$792.32K$586.90K-25.93%-$389.81-$119.94+69.23%
Q3 2017

Sep 1, 2017

—$79.41K—-$389.81-$359.82+7.69%
Q2 2017

May 30, 2017

—$73.41K—-$269.87-$239.88+11.11%
Q4 2016

Dec 31, 2016

—-$1.76K——-$21.91—
Q4 2016

Nov 25, 2016

—$60.27K—-$9.00-$539.73-5897.00%
Q3 2016

Aug 26, 2016

$60.44K$54.39K-10.00%-$419.79-$239.88+42.86%
Q2 2016

May 27, 2016

—$56.60K—-$269.87-$359.82-33.33%
Q4 2015

Dec 31, 2015

—$27.03K——$2.94—
Q4 2015

Nov 27, 2015

$326.66K$65.99K-79.80%-$239.88-$899.55-275.00%
Q3 2015

Aug 27, 2015

$53.77K$71.70K+33.33%-$209.90-$419.79-100.00%
Q2 2015

May 29, 2015

———-$359.82-$119.94+66.67%
Q1 2015

Mar 27, 2015

———-$246.98-$599.70-142.81%
Q4 2014

Dec 1, 2014

———-$719.64-$299.85+58.33%
Q3 2014

Sep 2, 2014

———-$1079.46-$599.70+44.44%
Q2 2014

May 29, 2014

———-$689.66-$659.67+4.35%
Q1 2014

Mar 30, 2014

———-$31.50-$66.00-109.52%
Q4 2013

Nov 29, 2013

———-$42.00$30.00+171.43%
Q2 2013

Jun 30, 2013

————-$38.65—
Q1 2013

Mar 31, 2013

————-$62.40—
Q4 2012

Dec 31, 2012

————-$332.55—
Q3 2012

Sep 30, 2012

————$44.17—
Q2 2012

Jun 30, 2012

————-$33.73—
Q1 2012

Mar 31, 2012

————-$28.87—
Q4 2011

Dec 31, 2011

—$111.43K——-$95.99—
Q3 2011

Sep 30, 2011

—$119.10K——-$20.03—
Q2 2011

Jun 30, 2011

—$130.55K——-$43.81—
Q1 2011

Mar 31, 2011

—$127.36K——-$42.83—
Q4 2010

Dec 31, 2010

—$152.04K——-$40.31—
Q3 2010

Sep 30, 2010

—$129.51K——-$40.98—